2m 2m 2m 2m 2m 2m 2m
CYTEK BIOSCI (CTKB)
NASDAQ
$5.44-$0.06 (-1.09%)
Price as of Oct 22, 2026 7:30 PM EDT- $714.9MMarket Cap
- 33.82%1-Year Change
- Medical DevicesIndustry
CYTEK BIOSCI (CTKB)
$5.44-$0.06 (-1.09%)
CTKB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.50 | ||
Change | +$0.16 (+3.00%) | ||
Open | $5.26 | ||
High | $5.54 | ||
Low | $5.24 | ||
Previous Close | $5.34 | ||
Volume | 1,093,138 | ||
30-Day Average Volume | 1,506,032 | ||
1-Week Change | 1.95% | ||
1-Month Change | 4.17% | ||
1-Year Change | 33.82% | ||
3-Year Change | 18.03% | ||
5-Year Change | -77.02% | ||
Fundamentals | |||
Shares Outstanding | 130.0M | ||
Total Assets | $446.9M | ||
Market Cap | $714.9M | ||
Enterprise Value | $643.1M | ||
Period: QTR TTM FY | |||
Revenue | $32.6M | ||
Net Income | -$12.2M | ||
Free Cash Flow | -$849,000.00 | ||
EBIT | -$11.6M | ||
EBITDA | -$9.6M | ||
Net Working Capital | $293.6M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -67 | ||
Enterprise Value/Revenue | 20 | ||
P/B | 2 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -842 | ||
Price/Operating Cash Flow | 523 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue